The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient ...

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar ...

A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight - without causing nausea ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...

Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body ...

Mankind’s domestic business crossed ₹10,000 crore in FY25, and the company is targeting 26% growth in FY26. Chronic therapies, which now make up 37% of revenue, will be a major growth driver.

Experts call for stronger regulation of digital food marketing to counter the increasing risk for obesity and teens’ ...